Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth. (Q43894344)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11863114 AND SRC:MED&resulttype=core&format=json

7 December 2019

title

Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11863114 AND SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11863114 AND SRC:MED&resulttype=core&format=json

7 December 2019

Fortunato Ciardiello

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11863114 AND SRC:MED&resulttype=core&format=json

7 December 2019

Luca Gianni

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11863114 AND SRC:MED&resulttype=core&format=json

7 December 2019

author name string

M Campiglio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11863114 AND SRC:MED&resulttype=core&format=json

7 December 2019

Luca A De

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11863114 AND SRC:MED&resulttype=core&format=json

7 December 2019

G Somenzi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11863114 AND SRC:MED&resulttype=core&format=json

7 December 2019

M Maiello

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11863114 AND SRC:MED&resulttype=core&format=json

7 December 2019

D S Salomon

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11863114 AND SRC:MED&resulttype=core&format=json

7 December 2019

S Menard

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11863114 AND SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11863114 AND SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11863114 AND SRC:MED&resulttype=core&format=json

7 December 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11863114 AND SRC:MED&resulttype=core&format=json

7 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11863114 AND SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

65-72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11863114 AND SRC:MED&resulttype=core&format=json

Epidermal growth factor-related peptides and their receptors in human malignancies

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDF020

Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDF020

The epidermal growth factor receptor and its ligands as therapeutic targets in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDF020

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDF020

Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDF020

erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDF020

Inhibition of erbB-2-positive breast cancer cell growth by erbB-2 antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDF020

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDF020

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDF020

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDF020

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDF020

Antibody-induced activation of p185HER2 in the human lung adenocarcinoma cell line Calu-3 requires bivalency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDF020

In vitro and in vivo stability and anti-tumour efficacy of an anti-EGFR/anti-CD3 F(ab')2 bispecific monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDF020

p53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDF020

Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDF020

The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDF020

Akt signaling: linking membrane events to life and death decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDF020

PI3K: downstream AKTion blocks apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDF020

Expression of messenger RNA for amphiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDF020

Epidermal growth factor receptors in breast cancer: Association with early relapse and death, poor response to hormones and interactions with neu

21 January 2018

1 reference

https://api.crossref.org/works/10.1093/ANNONC/MDF020

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDF020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11863114 AND SRC:MED&resulttype=core&format=json

7 December 2019

1 reference